Knowledge of hypertension and its therapy in lay people

  • Abraham Simatupang Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Kristen Indonesia
  • Fransiska Sitompul Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Kristen Indonesia
  • Linggom Kurniaty Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Kristen Indonesia
  • Mulyadi Djojosaputro Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Kristen Indonesia
  • Romauli Lumbantobing Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Kristen Indonesia
  • Hertina Silaban Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Kristen Indonesia
Keywords: hypertension, antihypertensive, adherence, knowledge, awareness

Abstract

Hypertension is one of the non-communicable diseases that is becoming a global health problem. Hypertension  can be identified by systolic blood pressure  of 140 mmHg and diastolic 90 mmHg . Uncontrolled hypertension can lead to  complications such as stroke, ischemic heart disease, heart attack, heart failure,  kidney failure, blindness, etc. According to Basic Health Research  2018  ( Ris et  Kesehatan Dasar 2018/Ris kesdas 2018) the prevalence of hypertension for >18  years  old wa s 8.4%, and through measurements taken in health care facilities by  34.1%. Prevalence in the city was 34.4%, in the village was 33.7%, while according  to gender 31.3% f or  male and 36.9%  for  female. The study  aimed to  find out the  knowledge and awareness of laypeople on hypertension and its therapy. This was  a cross-sectional online study with 11 questions. Respondents were recruited from  social media groups. The  results showed 5 00 respondents (62.8 % female and  37.2  % male) involved in this study . The most  common  age range was 21-40 years (36.2  %),  followed by  41-55 years (38.2%) , and the least was 56-65 years old (18.4%). Seventy-two percent of respondents did not have hypertension, and 9% said they  did not know. Fifty-three percent of respondents knew about the value of high  blood pressure, and 89%  of the  respondents said hypertension should be treated  regularly. The most hypertension complications answered by respondents were  stroke (40%), heart attack (26%) , and heart failure (16%). Amlodipine was the  most mentioned by  the  respondents,  and  the second was ACE-inhibitor. However,  omeprazole and omega-3  were  also mentioned as anti-hypertension. Genetic s and  a  high salt diet were risk factors that many respondents chose. In  conclusi on, the  r espondents have a good understanding  of hypertension. Information related to  behaviour is needed to discontinue the increasing prevalence.   

References

1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol [Internet]. 2020;16(4):223–37. Available from: http://dx.doi.org/10.1038/s41581-019-0244-2
2. Laporan Nasional Riskesdas. Laporan_Nasional_RKD2018_FINAL.pdf [Internet]. Badan Penelitian dan Pengembangan Kesehatan. 2018. p. 198. Available from: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf
3. Cosimo Marcello B, Maria Domenica A, Gabriele P, Elisa M, Francesca B. Lifestyle and Hypertension: An Evidence-Based Review. J Hypertens Manag. 2018;4(1):1–10.
4. Valenzuela PL, Carrera-Bastos P, Gálvez BG, Ruiz-Hurtado G, Ordovas JM, Ruilope LM, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18(4):251–75.
5. Peacock E, Krousel-Wood M. Adherence to Antihypertensive Therapy. Med Clin North Am [Internet]. 2017;101(1):229–45. Available from: http://dx.doi.org/10.1016/j.mcna.2016.08.005
6. Burnier M, Egan BM. Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management. Circ Res. 2019;124(7):1124–40.
7. Jongen VW, Lalla-Edward ST, Vos AG, Godijk NG, Tempelman H, Grobbee DE, et al. Hypertension in a rural community in South Africa: What they know, what they think they know and what they recommend. BMC Public Health. 2019;19(1):1–10.
8. Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012;59(6):1124–31.
9. Perhimpunan Dokter Hipertensi Indonesia. Konsensus Hipertensi. 2019;118. Available from: http://www.inash.or.id/upload/event/event_Update_konsensus_2019123191.pdf
10. Pirasath S, Kumanan T, Guruparan M. A Study on Knowledge, Awareness, and Medication Adherence in Patients with Hypertension from a Tertiary Care Centre from Northern Sri Lanka. Int J Hypertens. 2017;1–6.
11. Malik A, Yoshida Y, Erkin T, Salim D, Hamajima N. Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. Nagoya J Med Sci. 2014;76(3–4):255–63.
12. Hossain MM, Tasnim S, Sharma R, Sultana A, Shaik AF, Faizah F, et al. Digital interventions for people living with non-communicable diseases in India: A systematic review of intervention studies and recommendations for future research and development. Digit Heal. 2019;5:1–18.
Published
2022-11-17
Section
Articles